| First Author | Jezek J | Year | 2019 |
| Journal | J Cell Sci | Volume | 132 |
| Issue | 16 | PubMed ID | 31331961 |
| Mgi Jnum | J:278688 | Mgi Id | MGI:6357781 |
| Doi | 10.1242/jcs.230029 | Citation | Jezek J, et al. (2019) Synergistic repression of thyroid hyperplasia by cyclin C and Pten. J Cell Sci 132(16):jcs230029 |
| abstractText | The cyclin C-Cdk8 kinase has been identified as both a tumor suppressor and an oncogene depending on the cell type. The genomic locus encoding cyclin C (Ccnc) is often deleted in aggressive anaplastic thyroid tumors. To test for a potential tumor suppressor role for cyclin C, Ccnc alone, or Ccnc in combination with a previously described thyroid tumor suppressor Pten, was deleted late in thyroid development. Although mice harboring individual Pten or Ccnc deletions exhibited modest thyroid hyperplasia, the double mutant demonstrated dramatic thyroid expansion resulting in animal death by 22 weeks. Further analysis revealed that Ccnc(thyr-/-) tissues exhibited a reduction in signal transducer and activator of transcription 3 (Stat3) phosphorylation at Ser727. Further analysis uncovered a post-transcriptional requirement of both Pten and cyclin C in maintaining the levels of the p21 and p53 tumor suppressors (also known as CDKN1A and TP53, respectively) in thyroid tissue. In conclusion, these data reveal the first tumor suppressor role for cyclin C in a solid tumor model. In addition, this study uncovers new synergistic activities of Pten and cyclin C to promote quiescence through maintenance of p21 and p53. |
